NCT05642481View on ClinicalTrials.gov

Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed

UnknownOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
HIV-1-infection
Interventions
DIAGNOSTIC_TEST

Therapeutic drug monitoring in plasma of mother and child and in breastmilk

Measurement of drug concentration in plasma of mother and if possible of child and in breastmilk

Trial Locations (3)

6525GA

RECRUITING

Radboudumc, Nijmegen

Unknown

RECRUITING

Amsterdamumc, Amsterdam

RECRUITING

Erasmusmc, Rotterdam

Sponsors

Collaborators (1)

Erasmus Medical Center
All Listed Sponsors
collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

UMC Utrecht

OTHER

lead

Radboud University Medical Center

OTHER

NCT05642481 - Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed | Biotech Hunter | Biotech Hunter